Independent blending without pharmacokinetic modeling often leads to ingredient antagonism. For example, combining high doses of certain stimulants directly with untreated GABA can cause them to competitively block cellular uptake pathways, rendering both useless. Our OEM/ODM solutions provide a mathematically validated matrix where absorption pathways are optimized, ensuring maximum clinical bioavailability.

We utilize High-Performance Liquid Chromatography (HPLC) to quantify exact mass fractions of target markers (e.g., verifying ≥98% L-Theanine or 5-10% Withanolides) before they enter the blending hopper. Upon completion, we provide comprehensive Certificates of Analysis (COA) detailing the exact constituent ratios, heavy metal screens, and microbial limits.

Single-active melatonin only regulates circadian onset; it does not address anxiety or chronic stress. Our stack is a full-pathway intervention: 5-HTP supplies the serotonin precursor, GABA actively depresses central nervous system excitation, and Ashwagandha buffers the HPA-axis to prevent the mid-night cortisol spikes that cause fragmented sleep. It tackles the root cause, not just the symptom.

Yes. For Ready-to-Drink (RTD) applications, we substitute problematic crude extracts with highly specialized variants. For instance, we utilize enzymatically hydrolyzed Jujube Peptides (MW <1000Da) which are 100% water-soluble and clear, avoiding the muddy sedimentation typical of standard herbal powders. We also apply microencapsulated PS to ensure stability in aqueous solutions.

Absolutely. Xi'an Tihealth operates under ISO9001:2015. We strictly monitor active dosages against EFSA and FDA Generally Recognized As Safe (GRAS) limits. All components are screened for heavy metals, pesticide residues, and microbial counts (falling well below strict ICH Q3D limits) to ensure seamless, legal integration into your target market.